Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry
The aim of this study was to evaluate clinical characteristics, procedural details, and outcomes of patients undergoing elective multivessel percutaneous coronary intervention (MV-PCI) in Europe. A total of 7113 patients with stable coronary artery disease and at least two major epicardial vessels w...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2012
|
| In: |
Heart and vessels
Year: 2011, Volume: 27, Issue: 5, Pages: 453-459 |
| ISSN: | 1615-2573 |
| DOI: | 10.1007/s00380-011-0207-4 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s00380-011-0207-4 Verlag, Volltext: https://doi.org/10.1007/s00380-011-0207-4 
|
| Author Notes: | Timm Bauer, Helge Möllmann, Uwe Zeymer, Matthias Hochadel, Holger Nef, Franz Weidinger, Ralf Zahn, Christian W. Hamm, Jean Marco, Anselm K. Gitt |
| Summary: | The aim of this study was to evaluate clinical characteristics, procedural details, and outcomes of patients undergoing elective multivessel percutaneous coronary intervention (MV-PCI) in Europe. A total of 7113 patients with stable coronary artery disease and at least two major epicardial vessels with ≥70% stenosis were included in this analysis of the contemporary Euro Heart Survey PCI registry. Patients undergoing MV-PCI (n = 3376, 47.5%) were compared with those with single-vessel PCI (SV-PCI) (n = 3737, 52.5%). Patients with MV-PCI were more likely to have congestive heart failure, whereas those with SV-PCI more often suffered from noncardiac comorbidities. Hospital mortality (0.1% vs 0.3%) and the incidence of nonfatal postprocedural myocardial infarction (1.0% vs 0.7%) were low in patients with MV-PCI and SV-PCI. In the multivariate analysis, no significant difference in the incidence of hospital death (odds ratio (OR) 0.44, 95% confidence interval (CI) 0.15-1.27) could be observed between the two groups. However, the risk for postprocedural myocardial infarction (OR 1.57, 95% CI 0.93-2.67) tended to be higher among patients undergoing MV-PCI. Independent determinants for performing MV-PCI were age, comorbidities, and coronary anatomy. In Europe almost half of all patients with multivessel disease were treated with MV-PCI. Hospital complications were low, but a trend toward a higher rate of postprocedural myocardial infarctions was seen in patients with MV-PCI. |
|---|---|
| Item Description: | First online: 09 November 2011 Gesehen am 09.11.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1615-2573 |
| DOI: | 10.1007/s00380-011-0207-4 |